Viewing Study NCT01390805


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-04-13 @ 3:01 PM
Study NCT ID: NCT01390805
Status: COMPLETED
Last Update Posted: 2017-05-16
First Post: 2011-07-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module